financetom
Business
financetom
/
Business
/
Amazon-backed Anthropic Introduces AI Capability to Perform Complex Computer Tasks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon-backed Anthropic Introduces AI Capability to Perform Complex Computer Tasks
Oct 22, 2024 12:34 PM

12:16 PM EDT, 10/22/2024 (MT Newswires) -- Amazon ( AMZN ) -backed artificial intelligence startup Anthropic said Tuesday that it has introduced a capability in public beta form called Computer Use.

Computer Use is now available on the application programming interface allowing developers to direct Anthropic's Claude chatbot software "to use computers the way people do -- by looking at a screen, moving a cursor, clicking buttons, and typing text," the company said.

The goal is to enable developers to use this capability to automate repetitive processes, develop and test software, and carry out open-ended tasks like research, the company said, adding that they have come up with new classifiers to identify when the capability is being used and whether harm is occurring.

"We're releasing computer use early for feedback from developers, and expect the capability to improve rapidly over time," as it is currently in an experimental phase, the company said.

The company also launched an upgraded version of Claude 3.5 Sonnet and introduced a new model, dubbed Claude 3.5 Haiku, which will be released later this month.

Price: 189.52, Change: +0.44, Percent Change: +0.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TransCode Therapeutics Says Safety Review Committee Approves Opening of Fourth Group in Phase 1 Trial to Treat Metastatic Cancers
TransCode Therapeutics Says Safety Review Committee Approves Opening of Fourth Group in Phase 1 Trial to Treat Metastatic Cancers
Mar 13, 2025
08:26 AM EDT, 03/13/2025 (MT Newswires) -- TransCode Therapeutics ( RNAZ ) said Thursday that the Safety Review Committee, monitoring its phase 1 clinical study, has unanimously approved to open a fourth group of patients based on favorable safety data from the three patients in group 3 for multiple metastatic cancers treatment. The company is evaluating TTX-MC138 therapeutic candidate in...
Dollar General Q4 Revenue Crushes Estimate As Sales In New Stores Pick Up; Stock Jumps
Dollar General Q4 Revenue Crushes Estimate As Sales In New Stores Pick Up; Stock Jumps
Mar 13, 2025
On Thursday, Dollar General Corp ( DG ) shares are trading higher in premarket after the company reported fourth-quarter FY24 earnings today. The company reported fourth-quarter sales growth of 4.5% year-on-year to $10.304 billion, beating the analyst consensus estimate of $10.264 billion. Same-store sales increased 1.2% versus last year, driven by an increase of 2.3% in average transaction amount and...
Ballard Power Up 4.1% Pre-market as Q4 Loss Narrows While Revenue Falls by Nearly Half
Ballard Power Up 4.1% Pre-market as Q4 Loss Narrows While Revenue Falls by Nearly Half
Mar 13, 2025
08:28 AM EDT, 03/13/2025 (MT Newswires) -- Ballard Power Systems ( BLDP ) was last seen up 4.1% in pre-market Nasdaq trading after the fuel-cell company said its fourth-quarter loss narrowed even as revenue fell by nearly half. The company said it lost US$46.5 million, or US$0.16 per share, in the period, compared with a year-prior loss of US$48.9 million,...
Vir Biotechnology Enrolls First Patient in Phase 3 Chronic Hepatitis Delta Trial
Vir Biotechnology Enrolls First Patient in Phase 3 Chronic Hepatitis Delta Trial
Mar 13, 2025
08:29 AM EDT, 03/13/2025 (MT Newswires) -- Vir Biotechnology ( VIR ) said Thursday it has enrolled the first patient in a phase 3 study that will evaluate the efficacy and safety of its drug tobevibart in combination with elebsiran as a potential treatment for chronic hepatitis delta. The trial is designed to provide the registrational data for submission to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved